glp-1 receptor agonist contraindications Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists Frontiers | GLP-1 Receptor Agonists:
Description
Abstract This large community-based cohort study investigates the impact of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), specifically Liraglutide and Semaglutide, on the risk of developing psychiatric conditions such as depression, anxiety, and suicidal behaviors in patients with obesity
Dehydration affects skin turgor and nerve function
Rapid weight loss Faster weight loss increases the likelihood of lean mass loss
This holistic mechanism is why GLP-1s are considered a long-term solution
Although GLP-1 agonists have many positive benefits, they do have a number of potential side effects
